401 Episodes

  1. Episode 83: Is cabozantinib the new standard of care in papillary renal cancer?

    Published: 2/13/2021

  2. Episode 81: Noah Hahn discusses front line cisplatin-ineligible PD-L1 data from 361 and 130

    Published: 2/13/2021

  3. Episode 80: Results for Darolutamide in non-metastatic CRPC - the Aramis trial

    Published: 2/13/2021

  4. Episode 79: Adjuvant nivolumab in operable urothelial cancer

    Published: 2/13/2021

  5. Episode 78: Enfortumab Vedotin Special: EV301 randomised trial and EV201 in urothelial cancer

    Published: 2/12/2021

  6. Episode 77: The Uromigos Paper of the Month - Nadofaragene for BCG unresponsive NMIBC

    Published: 2/6/2021

  7. Episode 76: Tom Hutson discusses lenvatinib and everolimus

    Published: 1/22/2021

  8. Episode 75: The Uromigos meet APCCC - bone health and bone disease in prostate cancer with Bertrand Tombal

    Published: 1/14/2021

  9. Episode 74: The Uromigos meet APCCC Round 2: First line treatment - low vs high volume; chemo vs abi/enza

    Published: 1/11/2021

  10. Episode 73: The Uromigos meet APCCC in a discussion on oligometastatic prostate cancer @APCCC_Lugano

    Published: 1/8/2021

  11. Episode 72: Uromigos Christmas Special - Renal cancer year in review

    Published: 12/21/2020

  12. Episode 71: Bladder Cancer Uromigos Christmas Special with Matt Galsky

    Published: 12/18/2020

  13. Episode 70: The Uromigos Prostate Cancer Christmas Special with Chuck Ryan

    Published: 12/11/2020

  14. Episode 69: Testis Cancer Christmas Special: 2020 year in review

    Published: 12/9/2020

  15. Episode 68: Uromigos Paper of the Month - a molecular classification of renal cancer in Cancer Cell

    Published: 12/8/2020

  16. Episode 67: The Third Uromigos Debate - PD1/VEGF vs PD1/CTLA4 for front line renal cancer

    Published: 11/17/2020

  17. Episode 66: Uromigos Paper of the Month - Two papers in Nature Medicine on neoadjuvant immune combinations in bladder cancer

    Published: 11/9/2020

  18. Episode 65: Review of the International Kidney Cancer Symposium

    Published: 11/2/2020

  19. Episode 64: The Second Uromigos debate with Nobel Laureate Bill Kaelin on new biomarker vs new drugs in RCC

    Published: 10/28/2020

  20. Episode 63: The First Uromigos Debate: front line immune therapy vs maintenance avelumab in bladder cancer

    Published: 10/9/2020

17 / 21

Broadcasting the latest developments in GU cancer Hosted by Brian Rini and Tom Powles Brian Rini MD is a Professor of Cancer Research and Professor of Medicine (Hematology/Oncology), Vanderbilt-Ingram Cancer Center Tom Powles is the Director of Barts Cancer Centre, St Bartholomew's Hospital and Professor of Genitourinary Oncology, Queen Mary University of London